Organization | University of Tuebingen

University of Tuebingen Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: Tübingen Germany (1477)

Organization Overview

First Clinical Trial

1993

NCT00002544

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Alternative names

CCU Translational Immunology | CCU Translational Immunology, University Hospital Tübingen, Germany | CCU Translational Immunology, University Hospital Tuebingen, | Centre for Ophthalmology, University of Tuebingen | Children`s Hospital, Tuebingen | Department of dermatology, university of tuebingen | Department of General Neurology, University of Tuebingen Medical School, Tuebingen, Germany | Department of Internal Medicine, Internal Medicine II; Oncology, haematology, clinical immunology, rheumatology and pneumology University Hospital Tuebingen | Department of Internal Medicine VI: Psychosomatic Medicine and Psychotherapy, University of Tuebingen | Department of Neurosurgery Tuebingen | Department of Otorhinolaryngology, University of Tubingen | Department of Psychology, University of Tuebingen, Germany | Department of Urology, University of Tuebingen | Dept. of Dermatology, University Hopsital Tuebingen, Germany | Dept. of Neonatology, Tuebingen University Hospital | Dept. of Psychiatry and Psychotherapy, Hospital Sigmaringen, University of Tuebingen | Dept. of Urology, University Hospital Tübingen, Germany | Diakonie Klinikum Stuttgart | Diakonieklinikum Stuttgart, Germany | Dr. Margarete Fischer Bosch Institute of Clinical Pharmacology and University of Tuebingen | Dr. Philipp Zanger, MD MSc DTM | Eberhard Karls University | Eberhard Karls University Tuebingen | Infectomed GbR Zentrum fuer medizinische Studien, Stuttgart | Insitut of Tropical Medicine, University of Tubingen | Institute for Clinical Epidemiology and applied Biometry, University Tuebingen | Institute of Tropical Medicine / Centre for Clinical Trials, Eberhard Karls University | Institute of Tropical Medicine, University of Tuebingen | Institute of Tropical Medicine, University of Tuebingen, Wilhelmstr. 27, Germany | Joachim Riethmueller, Dr. med. | KKE Translational Immunology, University Hospital Tübingen | Klinik für Kinder- und Jugendmedizin Tübingen | Klinikum der Landeshauptstadt Stuttgart gKAö | Klinikum Stuttgart | Kreiskliniken Reutlingen | Kreiskliniken Reutlingen GmbH | Marienhospital Stuttgart | Medical Center II, University of Tuebingen, Germany | Medical Center University Hospital of Tuebingen | Medical Center University Hospital Tuebingen | Medical Center University of Tuebingen | Method Center, University of Tuebingen, Germany | PD Dr. Derek Zieker | Principal Investigator: Univ. Hospital Tuebingen, Dept. of Clinical Pharmacology | Prof. Dr. Katrin Giel | Robert Bosch Gesellschaft für Medizinische Forschung mbH | Robert-Bosch-Hospital, Stuttgart, Germany | Robert Bosch-Krankenhaus Stuttgart | Robert Bosch Krankenhaus, Stuttgart, Germany | Robert Bosch Medical Center | South West German Cancer Center, Medical Center II, University of Tuebingen | Tubingen | Tuebingen Clinical Hospital | Tuebingen University | Tuebingen University Hospital | Universitats Kinderklinik Tubingen | Universitats Kinderklinik Tubingen, Germany | Universität Tübingen | University-Children's Hospital TÃ¼bingen | University Children’s Hospital Tuebingen | University Children's Hospital Tuebingen / University Hospital Zurich, Department of Neonatology | University Department of General, Visceral and TransplantSurgery Tuebingen | University Hospital, Eberhard Karls University Tuebingen, Germany | University Hospital of TÃ¼bingen | University Hospital of Tübingen | University Hospital of Tuebingen | University-Hospital of Tuebingen, Department of General Neurology | University Hospital of Tuebingen, Germany | University Hospital TÃ¼bingen | University hospital Tübingen | University Hospital Tübingen | University Hospital Tübingen, Deparment for Neurology and Stroke | University Hospital Tübingen, Institute of Tropical Medicine | University Hospital Tuebingen | University Hospital Tuebingen, Center for Ophthalmology | University Hospital Tuebingen, Department of Neurosurgery | University Hospital Tuebingen, Department of oncology, hematology, rheumatology | University Hospital Tuebingen (Germany) | University Hospital Tuebingen, Germany | University Hospital Tuebingen, Germany; Dept. for Pediatric Gastroenterology and Hepatology | University Hospital Tuebingen (PI until 30Nov2004) | University of Tuebingen, Department of dermatology | University of Tuebingen, Department of Dermatology | University of Tuebingen, Dept. of Immunology | University of Tuebingen, Dept. of Medicine 2 | University of Tuebingen, Germany | University of Tuebingen Medical Center | University of Tuebingen, Paediatric Department | University Tuebingen | University Women's Hospital Tübingen | Universtitätsklinikum Tübingen | Zentrum fur Humangenetik Tuebingen | Zentrum für klinische Studien der UNiversitätsklinik Tübingen

University of Tuebingen Report issue

Drugs in Phase 4 Trials (20)

Drugs in Phase 3 Trials (77)

Drugs in Phase 2 Trials (90)

Drugs in Phase 1 Trials (38)

Drugs in Other Trials (36)

Experimental Indications (Clinical Trials, Phases 1-4)

Overview